NHS Logo

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?

Bansi, L.K.

Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? - 2008

NMUH Staff Publications 22

<div style="line-height: 17.999801635742188px;"><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">OBJECTIVE:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 8pt;"><span style="font-size: 10pt;">We investigated whether&nbsp;<span class="highlight">previous</span>&nbsp;<span class="highlight">treatment</span>&nbsp;<span class="highlight">interruptions</span>&nbsp;are&nbsp;<span class="highlight">associated</span>&nbsp;with a raised risk of&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;in individuals who have attained virological suppression.</span></span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">METHODS:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 10pt;">All&nbsp;<span class="highlight">patients</span>&nbsp;achieving an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load while on&nbsp;<span class="highlight">therapy</span>&nbsp;were followed until&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;or the time of the last&nbsp;<span class="highlight">viral</span>&nbsp;load. Poisson regression was used to describe the independent impact of&nbsp;<span class="highlight">treatment</span>&nbsp;<span class="highlight">interruptions</span>&nbsp;on&nbsp;<span class="highlight">rebound</span>&nbsp;<span class="highlight">rates</span>.</span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">RESULTS:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 10pt;">A total of 12,977&nbsp;<span class="highlight">patients</span>&nbsp;from the United Kingdom Collaborative HIV Cohort (UK CHIC) Study achieved a&nbsp;<span class="highlight">viral</span>&nbsp;load of less than 50 copies/ml. These&nbsp;<span class="highlight">patients</span>&nbsp;contributed a total of 37,314 person-years of follow-up. The overall&nbsp;<span class="highlight">rebound</span>&nbsp;rate was 8.07 (7.78, 8.36) per 100 person-years. In adjusted analyses,&nbsp;<span class="highlight">rates</span>&nbsp;of&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;were up to 64%&nbsp;<span class="highlight">higher</span>&nbsp;(rate ratio 1.64; 1.43, 1.88) in those who had previously interrupted&nbsp;<span class="highlight">therapy</span>&nbsp;compared with those who had not.&nbsp;<span class="highlight">Patients</span>&nbsp;who had interrupted at detectable&nbsp;<span class="highlight">viral</span>&nbsp;loads had up to a 74% (1.74; 1.42, 2.14)&nbsp;<span class="highlight">higher</span>&nbsp;chance of rebounding compared with those who had not interrupted with a detectable&nbsp;<span class="highlight">viral</span>&nbsp;load. We found no evidence to suggest interrupting&nbsp;<span class="highlight">treatment</span>&nbsp;at an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load was&nbsp;<span class="highlight">associated</span>&nbsp;with&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>.</span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">CONCLUSION:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 8pt;"><span style="font-size: 10pt;">Among&nbsp;<span class="highlight">patients</span>&nbsp;with an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load, having previously interrupted&nbsp;<span class="highlight">therapy</span>&nbsp;while the&nbsp;<span class="highlight">viral</span>&nbsp;load was detectable is&nbsp;<span class="highlight">associated</span>&nbsp;with a raised risk of&nbsp;<span class="highlight">rebound</span>.</span></span></p></div>

02699370
London Health Libraries Consortium Privacy notice and Membership terms and conditions